Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1996 Aug;51(Suppl 2):S16–S22. doi: 10.1136/thx.51.suppl_2.s16

18F-fluorodeoxyglucose PET scans in lung cancer.

J M Hughes 1
PMCID: PMC1090701  PMID: 8869347

Full text

PDF
S21

Images in this article

S20Image
on p.S20
S17Image
on p.S17
S17Image
on p.S17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnbaum M. J., Haspel H. C., Rosen O. M. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science. 1987 Mar 20;235(4795):1495–1498. doi: 10.1126/science.3029870. [DOI] [PubMed] [Google Scholar]
  2. Brown R. S., Fisher S. J., Wahl R. L. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med. 1993 Jan;34(1):75–82. [PubMed] [Google Scholar]
  3. Brudin L. H., Valind S. O., Rhodes C. G., Pantin C. F., Sweatman M., Jones T., Hughes J. M. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med. 1994 Apr;21(4):297–305. doi: 10.1007/BF00947964. [DOI] [PubMed] [Google Scholar]
  4. Chin R., Jr, Ward R., Keyes J. W., Choplin R. H., Reed J. C., Wallenhaupt S., Hudspeth A. S., Haponik E. F. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2090–2096. doi: 10.1164/ajrccm.152.6.8520780. [DOI] [PubMed] [Google Scholar]
  5. Dales R. E., Stark R. M., Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1096–1101. doi: 10.1164/ajrccm/141.5_Pt_1.1096. [DOI] [PubMed] [Google Scholar]
  6. Dewan N. A., Gupta N. C., Redepenning L. S., Phalen J. J., Frick M. P. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 1993 Oct;104(4):997–1002. doi: 10.1378/chest.104.4.997. [DOI] [PubMed] [Google Scholar]
  7. Dewan N. A., Reeb S. D., Gupta N. C., Gobar L. S., Scott W. J. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest. 1995 Aug;108(2):441–446. doi: 10.1378/chest.108.2.441. [DOI] [PubMed] [Google Scholar]
  8. Duhaylongsod F. G., Lowe V. J., Patz E. F., Jr, Vaughn A. L., Coleman R. E., Wolfe W. G. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg. 1995 Jul;110(1):130–140. doi: 10.1016/S0022-5223(05)80018-2. [DOI] [PubMed] [Google Scholar]
  9. Flier J. S., Mueckler M. M., Usher P., Lodish H. F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 1987 Mar 20;235(4795):1492–1495. doi: 10.1126/science.3103217. [DOI] [PubMed] [Google Scholar]
  10. Frank A., Lefkowitz D., Jaeger S., Gobar L., Sunderland J., Gupta N., Scott W., Mailliard J., Lynch H., Bishop J. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1495–1512. doi: 10.1016/0360-3016(94)00622-R. [DOI] [PubMed] [Google Scholar]
  11. Gupta N. C., Frank A. R., Dewan N. A., Redepenning L. S., Rothberg M. L., Mailliard J. A., Phalen J. J., Sunderland J. J., Frick M. P. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1992 Aug;184(2):441–444. doi: 10.1148/radiology.184.2.1620844. [DOI] [PubMed] [Google Scholar]
  12. Hübner K. F., Buonocore E., Singh S. K., Gould H. R., Cotten D. W. Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med. 1995 Apr;20(4):293–298. doi: 10.1097/00003072-199504000-00001. [DOI] [PubMed] [Google Scholar]
  13. Inoue T., Kim E. E., Komaki R., Wong F. C., Bassa P., Wong W. H., Yang D. J., Endo K., Podoloff D. A. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med. 1995 May;36(5):788–793. [PubMed] [Google Scholar]
  14. Jones H. A., Clark R. J., Rhodes C. G., Schofield J. B., Krausz T., Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med. 1994 Jun;149(6):1635–1639. doi: 10.1164/ajrccm.149.6.7516252. [DOI] [PubMed] [Google Scholar]
  15. Kubota K., Matsuzawa T., Fujiwara T., Ito M., Hatazawa J., Ishiwata K., Iwata R., Ido T. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med. 1990 Dec;31(12):1927–1932. [PubMed] [Google Scholar]
  16. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992 Nov;33(11):1972–1980. [PubMed] [Google Scholar]
  17. Langen K. J., Braun U., Rota Kops E., Herzog H., Kuwert T., Nebeling B., Feinendegen L. E. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med. 1993 Mar;34(3):355–359. [PubMed] [Google Scholar]
  18. Lewis P., Griffin S., Marsden P., Gee T., Nunan T., Malsey M., Dussek J. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 1994 Nov 5;344(8932):1265–1266. doi: 10.1016/s0140-6736(94)90753-6. [DOI] [PubMed] [Google Scholar]
  19. Lindholm P., Minn H., Leskinen-Kallio S., Bergman J., Ruotsalainen U., Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med. 1993 Jan;34(1):1–6. [PubMed] [Google Scholar]
  20. Monakhov N. K., Neistadt E. L., Shavlovskil M. M., Shvartsman A. L., Neifakh S. A. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst. 1978 Jul;61(1):27–34. doi: 10.1093/jnci/61.1.27. [DOI] [PubMed] [Google Scholar]
  21. Nolop K. B., Rhodes C. G., Brudin L. H., Beaney R. P., Krausz T., Jones T., Hughes J. M. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 1987 Dec 1;60(11):2682–2689. doi: 10.1002/1097-0142(19871201)60:11<2682::aid-cncr2820601118>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  22. Pantin C. F., Valind S. O., Sweatman M., Lawrence R., Rhodes C. G., Brudin L., Britten A., Hughes J. M., Turner-Warwick M. Measures of the inflammatory response in cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1988 Nov;138(5):1234–1241. doi: 10.1164/ajrccm/138.5.1234. [DOI] [PubMed] [Google Scholar]
  23. Patz E. F., Jr, Lowe V. J., Goodman P. C., Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest. 1995 Dec;108(6):1617–1621. doi: 10.1378/chest.108.6.1617. [DOI] [PubMed] [Google Scholar]
  24. Patz E. F., Jr, Lowe V. J., Hoffman J. M., Paine S. S., Burrowes P., Coleman R. E., Goodman P. C. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993 Aug;188(2):487–490. doi: 10.1148/radiology.188.2.8327702. [DOI] [PubMed] [Google Scholar]
  25. Patz E. F., Jr, Lowe V. J., Hoffman J. M., Paine S. S., Harris L. K., Goodman P. C. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology. 1994 May;191(2):379–382. doi: 10.1148/radiology.191.2.8153309. [DOI] [PubMed] [Google Scholar]
  26. Rege S. D., Hoh C. K., Glaspy J. A., Aberle D. R., Dahlbom M., Razavi M. K., Phelps M. E., Hawkins R. A. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer. 1993 Jul 1;72(1):82–90. doi: 10.1002/1097-0142(19930701)72:1<82::aid-cncr2820720117>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  27. Sazon D. A., Santiago S. M., Soo Hoo G. W., Khonsary A., Brown C., Mandelkern M., Blahd W., Williams A. J. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 1996 Jan;153(1):417–421. doi: 10.1164/ajrccm.153.1.8542152. [DOI] [PubMed] [Google Scholar]
  28. Scott W. J., Schwabe J. L., Gupta N. C., Dewan N. A., Reeb S. D., Sugimoto J. T. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group. Ann Thorac Surg. 1994 Sep;58(3):698–703. doi: 10.1016/0003-4975(94)90730-7. [DOI] [PubMed] [Google Scholar]
  29. Slosman D. O., Spiliopoulos A., Couson F., Nicod L., Louis O., Lemoine R., Donath A., Junod A. F. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun. 1993 Nov;14(11):955–961. doi: 10.1097/00006231-199311000-00004. [DOI] [PubMed] [Google Scholar]
  30. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
  31. WARBURG O. On the origin of cancer cells. Science. 1956 Feb 24;123(3191):309–314. doi: 10.1126/science.123.3191.309. [DOI] [PubMed] [Google Scholar]
  32. Wahl R. L., Quint L. E., Greenough R. L., Meyer C. R., White R. I., Orringer M. B. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology. 1994 May;191(2):371–377. doi: 10.1148/radiology.191.2.8153308. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES